European Commission Grants Authorization for Gilead’s Veklury® (remdesivir) for Treatment of COVID-19
- Veklury is the First Approved Treatment Option for COVID-19 in the European Union -- FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission has granted conditional marketing authorization for Veklury®(remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. The conditional marketing